Haisco Pharmaceutical Group Co., Ltd.

Haisco Pharmaceutical researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anesthesia and analgesic, endocrine system, enteral parenteral nutrition, cardiovascular, psychiatric, tumor-related, digestive liver, and diseases.

Haisco Pharmaceutical Group Co., Ltd. has licensing and research collaboration with Eli Lilly and Company to develop medicines across multiple therapeutic areas. Founded in 2000 and based in Shannan, China, Haisco Pharmaceutical was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. before rebranding in March 2016.